API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2023/02/21/2612072/0/en/CinCor-Pharma-Announces-Receipt-of-Minutes-from-End-of-Phase-2-Meeting-with-the-U-S-Food-and-Drug-Administration-on-Planned-Phase-3-Program-of-Baxdrostat.html
https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-acquire-cincor-for-cardiorenal-asset.html
https://www.fiercebiotech.com/biotech/cincors-hypertension-drug-loses-its-halo-after-phase-2-fail-plunging-stock-44
https://www.globenewswire.com/news-release/2022/11/07/2550309/0/en/CinCor-Pharma-Announces-Publication-in-the-New-England-Journal-of-Medicine-of-Phase-2-BrigHtn-Data-on-Selective-Aldosterone-Synthase-Inhibitor-Baxdrostat-in-Treatment-Resistant-Hyp.html
https://www.globenewswire.com/news-release/2022/10/25/2540780/0/en/CinCor-Pharma-Announces-Presentation-of-Phase-1-Clinical-Data-for-Baxdrostat-at-the-Upcoming-American-Society-of-Nephrology-Kidney-Week-2022.html
https://www.cincor.com/news-releases/news-release-details/cincor-pharma-announces-oral-presentation-phase-1-data
https://www.globenewswire.com/news-release/2022/08/22/2502123/0/en/CinCor-Pharma-Announces-Presentation-of-Phase-1-Clinical-Data-for-Baxdrostat-at-the-Upcoming-European-Society-of-Cardiology-2022-Congress.html
https://endpts.com/following-the-recent-playbook-cincor-raises-225m-on-back-of-positive-phii-readout/
https://www.cincor.com/news-releases/news-release-details/cincor-pharma-announces-last-patient-randomized-phase-2-halo